GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » Capex-to-Operating-Income

Paxman AB (FRA:B0F) Capex-to-Operating-Income : 1.07 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Paxman AB Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Paxman AB's Capital Expenditure for the three months ended in Mar. 2024 was €-0.70 Mil. Its Operating Income for the three months ended in Mar. 2024 was €0.65 Mil.

Hence, Paxman AB's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 1.07.


Paxman AB Capex-to-Operating-Income Historical Data

The historical data trend for Paxman AB's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB Capex-to-Operating-Income Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - 2.01

Paxman AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 1.07

Competitive Comparison of Paxman AB's Capex-to-Operating-Income

For the Medical Devices subindustry, Paxman AB's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paxman AB's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Paxman AB's Capex-to-Operating-Income falls into.



Paxman AB Capex-to-Operating-Income Calculation

Paxman AB's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-2.264) / 1.128
=2.01

Paxman AB's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.698) / 0.654
=1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paxman AB  (FRA:B0F) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Paxman AB Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Paxman AB's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Paxman AB (FRA:B0F) Business Description

Traded in Other Exchanges
Address
Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB (FRA:B0F) Headlines

No Headlines